Objective To explore the relationship between serum phosphate, arterial stiffness and left
ventricular mass (LVM) in patients with early-stage chronic kidney disease (CKD). Design A …

Background Increasing evidence indicated that phosphorus emerged as an important
cardiovascular risk factor in patients with chronic kidney disease (CKD). The fact that serum …

Background. The rate of decline in kidney function is a powerful predictor of cardiovascular
risk in patients with chronic kidney disease (CKD). Serum phosphate and increased arterial …

Background/Aims: A relationship with vascular dysfunction in chronic kidney disease
suggests a possible association of phosphate level with left ventricular hypertrophy …

Cardiovascular disease occurs in ESRD patients at rates that are far higher than is seen in
the general population, and cardiovascular deaths account for the majority of deaths among …

BACKGROUND: Higher serum phosphorus levels are associated with cardiovascular
disease (CVD) events in the general population, an association that may be stronger in men …

BACKGROUND: Elevated serum phosphate levels are associated with excess risk for
cardiovascular mortality in patients with and without chronic kidney disease and with …

Background Serum phosphate is a known risk factor for cardiovascular events and mortality
in people with chronic kidney disease (CKD), however data on the association of these …

Phosphate levels are consistently linked with cardiac calcification, cardiovascular disease
(CVD), and death in populations with chronic kidney disease. In addition, mechanistic …

Abstract Background and Aim: Due to increasing evidence suggesting a link between
hyperphosphatemia and cardiovascular disease (CVD), mediated through vascular …